Nautilus Biotechnology, Inc.
NAUT
$2.51
$0.041.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.52% | 9.71% | 9.51% | 5.58% | -6.98% |
| Total Depreciation and Amortization | -1.91% | -0.86% | 0.49% | -0.73% | 1.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.35% | -6.30% | -21.94% | -50.03% | 32.30% |
| Change in Net Operating Assets | -464.68% | 77.95% | -111.81% | 64.18% | -117.30% |
| Cash from Operations | -12.15% | 17.35% | 4.21% | 2.60% | -9.12% |
| Capital Expenditure | 41.63% | -5.56% | -80.82% | 78.40% | -43.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.51% | -94.15% | -24.63% | -48.24% | 661.08% |
| Cash from Investing | 74.12% | -96.88% | -25.82% | -47.42% | 594.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 427.78% | -95.91% | 214.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 427.78% | -95.91% | 214.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.55% | -968.09% | -78.20% | -75.93% | 213.48% |